TIANJIN MEDICAL UNIVERSITY
Tianjin Medical University (TMU)
(Chinese: 天津医科大学; pinyin: Tiānjīn Yīkē Dàxué) was founded in 1951;was the first medical institution approved by the State Council of the People's Republic of China. Hsien-I Chu, a renowned endocrinologist, was the first president of the university. The current president is Shang Yongfeng. In December 1993, with the approval of the State Education Council, the Tianjin Medical College and the Tianjin Second Medical College were integrated into the Tianjin Medical University.
In December 1996, the university was accepted
into Project 211, becoming one of the 97 key institutions (9 medical institutions) given
development priority by the State. It is a Chinese Ministry of Education Double First
Class Discipline University, with Double First Class status in certain disciplines.[2]
In 1981, the university was approved by the Academic Degree Committee of State Council
to confer the Doctorate Degree, Master's Degree and Bachelor's Degree and in 1988, was
permitted to set up seven-year medical program.
The University has a number of State-level Key Disciplines and Local-level Key
Disciplines. The Clinical Integration of Traditional Chinese medicine and Western
Medicine (Surgery) is a State-level Key Discipline. The eight Local-level Key
Disciplines are Endocrinology & Metabolic Disease, Oncology, Neurology, Medical Imaging,
Urinary Surgery, Cardiovascular Diseases, Nuclear Medicine and General Surgery. Three
Local-level Key Development Disciplines are Microbiology & Immunology, Ophthalmology and
Stomatology. The University has nine Research Institutions, one Key Laboratory of
Ministry of Health and nine Clinical Pharmacology Center of Ministry of Health. Over the
recent ten years, about three hundred medical researches passed the appraisals and
eleven researches won the national awards.
The University of Texas M. D. Anderson Cancer Center and Tianjin Medical University
Cancer Institute and Hospital, in Tianjin, China, on June 7, 2006 announced an agreement
to expand opportunities for collaborations in clinical, educational and translational
cancer research, building upon professional relationships between physicians and
scientists at both institutions that have spanned over a decade. The agreement
formalizes a cooperative framework to develop joint programs that support the
institutions' shared missions of eradicating cancer worldwide through scientific
discovery, advanced patient therapies, education and prevention.
In 2009, the Center for Molecular Medicine of Karolinska University Hospital and Tianjin
Medical University announced an agreement to build the Sino-Swedish Center for Molecular
Medicine.
Tianjin Medical University has also more than 50 partner universities in over 16
countries, 108 Guest-Professors of the famous research institutes from all over the
world, such as the Johns Hopkins University.
Over 1800 Medical Students recruited by China Lanka, have successfully completed their
MBBS Degree in China. Upon their return to Sri Lanka, they have successfully passed the
qualifying exam to obtain license to practice medicine in Sri Lanka. After having
obtained the license from Sri Lanka Medical Council, they practice medicine in
Government and Private hospitals in Sri Lanka and also work in foreign countries such as
USA, UK, Canada, Australia, and Switzerland.
We have helped some of the students who have passed the MBBS examination, to obtain
scholarships from Universities in China and study for their Master’s Degree in Medicine
[MD] in China.
